AllRock Bio
PrivateLast Round
Series A
Sep 16, 2025
Total Funding Raised
$50M
Company Overview
AllRock Bio is a biotechnology company developing therapies for cardiopulmonary and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AllRock Bio Comps
Public and private peers based on sector, stage, and business model.
AllRock Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 |
Key People
Founding team and executive leadership
AllRock Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village Biopartners | Series A |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 15, 2025
Grew 240% QoQ from 5 to 17 employees.
- Oct 21, 2025
Grew 750% QoQ, from 2 to 17 employees.
AllRock Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AllRock Bio's valuation, stock price, and market status.
